We are finding some crazy Rx trends that are translating into real world cost and care issues for our clients and their employees. Here’s a prime example. We recently found that a type 2 diabetes drug (GLUMETZA) increased in cost by 900%, nearly overnight.
After digging into it here’s what we found:
• An investment firm purchased the manufacturer
• The price of the drug quickly spiked under the new ownership
• The drug had a specific efficacy but was prescribed widely